Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07693205 · ClinicalTrials.gov registry record · Phase 4
A Prospective, Randomized, Subject- and Examiner-Masked, Multicenter Study Comparing Bilateral Clareon TruPlus and Bilateral Clareon Monofocal Intraocular Lens Implantation (Spherical and Toric) in Cataract Subjects
A Phase 4 study, sponsored by Berkeley Eye Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 180
- Enrollment target
NCT07693205: Recruiting Phase 4 study, sponsored by Berkeley Eye Center.
NCT07693205 is a Phase 4 study that is actively recruiting participants, run by Berkeley Eye Center. The registered enrollment target is 180 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07693205, a Phase 4 study, is actively recruiting participants, sponsored by Berkeley Eye Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 180 participants
- Enrollment target
Study Summary
This investigator-initiated trial is a prospective, randomized, parallel-group, bilateral implantation study comparing Clareon TruPlus versus Clareon monofocal intraocular lenses (IOLs). Spherical and toric models are permitted in both arms based on standardized preoperative planning and clinical indication. Subjects and postoperative examiners/technicians will be masked to IOL assignment; surgeons will not be masked. The overall structure is modeled after randomized bilateral implantation cataract study designs with a Month 3 primary endpoint visit.
Interventions
- DEVICE Clareon TruPlus
- DEVICE Clareon monofocal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2026-07 |
| Est. Completion | 2027-07 |
| Phase | Phase 4 |
What NCT07693205 shows while recruiting
NCT07693205 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 2 interventions - of which Clareon TruPlus is the first listed.
NCT07693205 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07693205 about?
NCT07693205 is a clinical study titled "A Prospective, Randomized, Subject- and Examiner-Masked, Multicenter Study Comparing Bilateral Clareon TruPlus and Bilateral Clareon Monofocal Intraocular Lens Implantation (Spherical and Toric) in Cataract Subjects". This investigator-initiated trial is a prospective, randomized, parallel-group, bilateral implantation study comparing Clareon TruPlus versus Clareon monofocal intraocular lenses (IOLs). Spherical and toric models are permitted in both arms based on standardized preoperative planning and clinical in...
What is the current status of trial NCT07693205?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 180 participants. The study started on 2026-07. Estimated completion is 2027-07.
What interventions are being tested in trial NCT07693205?
The interventions under investigation include: Clareon TruPlus (DEVICE), Clareon monofocal (DEVICE).
Who is sponsoring clinical trial NCT07693205?
This trial is sponsored by Berkeley Eye Center, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07693205's enrollment target sits among peer trials
180 466th of 2000 higher than 1,525 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia